1. Home
  2. ACET vs UPLD Comparison

ACET vs UPLD Comparison

Compare ACET & UPLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACET
  • UPLD
  • Stock Information
  • Founded
  • ACET 1947
  • UPLD 2010
  • Country
  • ACET United States
  • UPLD United States
  • Employees
  • ACET N/A
  • UPLD N/A
  • Industry
  • ACET Biotechnology: Pharmaceutical Preparations
  • UPLD Computer Software: Prepackaged Software
  • Sector
  • ACET Health Care
  • UPLD Technology
  • Exchange
  • ACET Nasdaq
  • UPLD Nasdaq
  • Market Cap
  • ACET 75.6M
  • UPLD 67.6M
  • IPO Year
  • ACET N/A
  • UPLD 2014
  • Fundamental
  • Price
  • ACET $0.91
  • UPLD $3.84
  • Analyst Decision
  • ACET Strong Buy
  • UPLD Hold
  • Analyst Count
  • ACET 4
  • UPLD 3
  • Target Price
  • ACET $5.67
  • UPLD $3.75
  • AVG Volume (30 Days)
  • ACET 513.3K
  • UPLD 349.1K
  • Earning Date
  • ACET 11-06-2024
  • UPLD 02-20-2025
  • Dividend Yield
  • ACET N/A
  • UPLD N/A
  • EPS Growth
  • ACET N/A
  • UPLD N/A
  • EPS
  • ACET N/A
  • UPLD N/A
  • Revenue
  • ACET N/A
  • UPLD $278,945,000.00
  • Revenue This Year
  • ACET N/A
  • UPLD N/A
  • Revenue Next Year
  • ACET N/A
  • UPLD N/A
  • P/E Ratio
  • ACET N/A
  • UPLD N/A
  • Revenue Growth
  • ACET N/A
  • UPLD N/A
  • 52 Week Low
  • ACET $0.81
  • UPLD $1.79
  • 52 Week High
  • ACET $3.62
  • UPLD $5.64
  • Technical
  • Relative Strength Index (RSI)
  • ACET 43.86
  • UPLD 42.79
  • Support Level
  • ACET $0.85
  • UPLD $3.76
  • Resistance Level
  • ACET $0.94
  • UPLD $4.12
  • Average True Range (ATR)
  • ACET 0.08
  • UPLD 0.35
  • MACD
  • ACET 0.00
  • UPLD -0.12
  • Stochastic Oscillator
  • ACET 22.16
  • UPLD 6.56

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its lead preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About UPLD Upland Software Inc.

Upland Software Inc is a provider of cloud-based enterprise work management software. The company provides a family of cloud-based enterprise work management software applications for the information technology, process excellence, finance, professional services and marketing functions within organizations. It services customers ranging from corporations and Government agencies to small- and medium-sized businesses engaged in the field of financial services, retail, technology, manufacturing, education, consumer goods, media, and telecommunications, Government, food and beverage, healthcare and life sciences, chemicals and travel and hospitality. The products of the company are Altify, BA Insight, InGenius, Panviva, Qvidian, RightAnswers and others.

Share on Social Networks: